Do you want to read an article? Please log in or register.
Efficacy and safety of brolucizumab versus aflibercept in eyes with polypoidal choroidal vasculopathy in Japanese participants of HAWK
Retinal DiseasesFurther Publications
Related content
Efficacy and Safety of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy in the PLANET Study: A Randomized Clinical Trial
JAMA Ophthalmol.
Lee WK, Iida T, Ogura Y, Chen SJ, Wong TY, Mitchell P, Ming Cheung GC, Zhang Z, Leal S, Ishibashi T, for the PLANET Investigators
Further Publications
Efficacy and Safety of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy: 2-Year Results of the PLANET Study
Am J Ophthalmol.
Wong TY, Ogura Y, Lee WK, Iida T, Chen SJ, Mitchell P, Gemmy Cheung CM, Zhang Z, Leal S, Ishibashi T, Planet Investigators
doi: 10.1016/j.ajo.
Macular Diseases
Efficacy and Safety of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: A Randomized Clinical Trial
JAMA Ophthalmol.
Koh A, Lai TYY, Takahashi K, Wong TY, Chen LJ, Ruamviboonsuk P, Tan CS, Feller C, Margaron P, Lim TH, Lee WK; EVEREST II study group
doi: 10.1001/
Macular Diseases
Incidence of New Choroidal Neovascularization in Fellow Eyes of Patients With Age-Related Macular Degeneration Treated With Intravitreal Aflibercept or Ranibizumab
JAMA Ophthalmol.
Parikh R, Avery RL, Saroj N, Thompson D, Freund KB
doi: 10.1001/jamaophthalmol.2019.1947.
Blindness and Vision ImpairmentMacular DiseasesSurgery and Intervention
Long-term outcomes of ranibizumab vs. aflibercept for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
Sci Rep
Jin KW, Kim JH, Park JY, Park SJ, Park KH, Lee JY, Woo SJ
doi: 10.1038/s41598-021-93899-x
RECOMMENDED
Macular Diseases
PREVALENCE OF POLYPOIDAL CHOROIDAL VASCULOPATHY IN WHITE PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION: Systematic Review and Meta-Analysis
Retina.
Lorentzen TD, Subhi Y, Sørensen TL
doi: 10.1097/IAE.
COMMENTED
Further Publications
Comparison of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: The EVEREST II Randomized Clinical Trial
★ 3
Recommended by
Prof. Dr Ke Yao, Faculty Member
★ 3
Recommended and commented by
Dr habil. Gábor Márk Somfai, PhD, Faculty Member
JAMA Ophthalmol
Lim TH, Lai TYY, Takahashi K, Wong TY, Chen LJ, Ruamviboonsuk P, Tan CS, Lee WK, Cheung CMG, Ngah NF, Patalauskaite R, Margaron P, Koh A, EVEREST II Study Group.
doi: 10.1001/jamaophthalmol.2020.2443
Glaucoma and Ocular Pressure
Efficacy and safety evaluation of benzalkonium chloride preserved eye-drops compared with alternatively preserved and preservative-free eye-drops in the treatment of glaucoma: a systematic review and meta-analysis
Br J Ophthalmol.
Hedengran A, Steensberg AT, Virgili G, Azuara-Blanco A, Kolko M
doi: 10.1136/bjophthalmol-2019-315623.
COMMENTED
Macular DiseasesRetinal Diseases
Risk of inflammation, retinal vasculitis and retinal occlusion-related events with brolucizumab: post-hoc review of HAWK and HARRIER
★ 2
Recommended by
Dr habil. Gábor Márk Somfai, PhD, Faculty Member
Ophthalmology
Monés J, Srivastava SK, Jaffe GJ, Tadayoni R, Albini TA, Kaiser PK, Holz FG, Korobelnik JF, Kim IK, Pruente C, Murray TG, Heier JS
doi: 10.1016/j.ophtha.2020.11.011